Voltar
Artigo Revisado por pares
BIBTEX RIS

Long-Term Efficacy and Safety of Efavirenz Dose Reduction to 200 mg Once Daily in a Caucasian Patient with HIV

2010; Adis, Springer Healthcare; Volume: 30; Issue: 6 Linguagem: Inglês

10.1007/bf03256910

ISSN

1179-1918

Autores

Salvador Cabrera Figueroa, Alicia Iglesias Gómez, Almudena Sánchez Martín, María de la Paz Valverde Merino, Alfonso Domínguez-Gil Hurlé, Miguel Cordero Sánchez,

Tópico(s)

Biochemical and Molecular Research

Referência(s)